AI-designed Protein Therapeutics
Medium Bio is developing new assays & AI models to design biomolecules, starting with antibodies. We believe that the most impactful AI developments will be derived from fast, accurate simulations of the biophysical world. In particular, biomolecule design will help create new therapies for various diseases, grow our understanding of nature, and create lasting abundance.
We are a venture-backed rapidly growing early stage startup. Now is the most exciting time to join us as we expand our AI & Bio team!